WuXi Bi­o­log­ics serves up $1.4B ex­pan­sion of re­search and man­u­fac­tur­ing cen­ter in Sin­ga­pore

While WuXi Bi­o­log­ics is con­tin­u­ing to work with US reg­u­la­tors on in­spec­tions of its fa­cil­i­ties, the com­pa­ny is al­so look­ing to ex­pand one of its …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.